No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache
Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a...
Ausführliche Beschreibung
Autor*in: |
Laura de Boni [verfasserIn] Alexandru Odainic [verfasserIn] Natalie Gancarczyk [verfasserIn] Luisa Kaluza [verfasserIn] Christian P. Strassburg [verfasserIn] Xenia A. K. Kersting [verfasserIn] Joseph M. Johnson [verfasserIn] Ullrich Wüllner [verfasserIn] Susanne V. Schmidt [verfasserIn] Jacob Nattermann [verfasserIn] Gabor C. Petzold [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2022 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Neurological Research and Practice - BMC, 2019, 4(2022), 1, Seite 7 |
---|---|
Übergeordnetes Werk: |
volume:4 ; year:2022 ; number:1 ; pages:7 |
Links: |
---|
DOI / URN: |
10.1186/s42466-022-00217-5 |
---|
Katalog-ID: |
DOAJ027378985 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ027378985 | ||
003 | DE-627 | ||
005 | 20230502100627.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s42466-022-00217-5 |2 doi | |
035 | |a (DE-627)DOAJ027378985 | ||
035 | |a (DE-599)DOAJ327e6e4c09b34600864468cf80edde8e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC321-571 | |
050 | 0 | |a RC346-429 | |
100 | 0 | |a Laura de Boni |e verfasserin |4 aut | |
245 | 1 | 0 | |a No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading symptom of Post-COVID diseases associated with neuronal damage such as vasculitis or autoimmune encephalitis. We here compared patients with mild Post-COVID-19 syndrome and persistent headache (persistent Post-COVID-19 headache) lasting longer than 12 weeks after the initial serological diagnosis, to patients with mild and severe COVID-19 and COVID-19-negative controls. Levels of neurofilament light chain and glial fibrillary astrocytic protein, i.e. markers of neuronal damage and reactive astrogliosis, were lower in blood from patients with persistent Post-COVID-19 headache compared to patients with severe COVID-19. Hence, our pilot serological study indicates that long-term Post-COVID-19 headache may not be a sign of underlying neuronal damage or neuroinflammation. | ||
650 | 4 | |a Post-acute sequelae of SARS-CoV-2 infection | |
650 | 4 | |a Post-COVID-19 | |
650 | 4 | |a Headache | |
650 | 4 | |a NfL | |
650 | 4 | |a GFAP | |
650 | 4 | |a Biomarkers | |
653 | 0 | |a Neurosciences. Biological psychiatry. Neuropsychiatry | |
653 | 0 | |a Neurology. Diseases of the nervous system | |
700 | 0 | |a Alexandru Odainic |e verfasserin |4 aut | |
700 | 0 | |a Natalie Gancarczyk |e verfasserin |4 aut | |
700 | 0 | |a Luisa Kaluza |e verfasserin |4 aut | |
700 | 0 | |a Christian P. Strassburg |e verfasserin |4 aut | |
700 | 0 | |a Xenia A. K. Kersting |e verfasserin |4 aut | |
700 | 0 | |a Joseph M. Johnson |e verfasserin |4 aut | |
700 | 0 | |a Ullrich Wüllner |e verfasserin |4 aut | |
700 | 0 | |a Susanne V. Schmidt |e verfasserin |4 aut | |
700 | 0 | |a Jacob Nattermann |e verfasserin |4 aut | |
700 | 0 | |a Gabor C. Petzold |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Neurological Research and Practice |d BMC, 2019 |g 4(2022), 1, Seite 7 |w (DE-627)1038162947 |x 25243489 |7 nnns |
773 | 1 | 8 | |g volume:4 |g year:2022 |g number:1 |g pages:7 |
856 | 4 | 0 | |u https://doi.org/10.1186/s42466-022-00217-5 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/327e6e4c09b34600864468cf80edde8e |z kostenfrei |
856 | 4 | 0 | |u https://doi.org/10.1186/s42466-022-00217-5 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2524-3489 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 4 |j 2022 |e 1 |h 7 |
author_variant |
l d b ldb a o ao n g ng l k lk c p s cps x a k k xakk j m j jmj u w uw s v s svs j n jn g c p gcp |
---|---|
matchkey_str |
article:25243489:2022----::oeooiaeiecfrernlaaerecieloiinuooi1ptetw |
hierarchy_sort_str |
2022 |
callnumber-subject-code |
RC |
publishDate |
2022 |
allfields |
10.1186/s42466-022-00217-5 doi (DE-627)DOAJ027378985 (DE-599)DOAJ327e6e4c09b34600864468cf80edde8e DE-627 ger DE-627 rakwb eng RC321-571 RC346-429 Laura de Boni verfasserin aut No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading symptom of Post-COVID diseases associated with neuronal damage such as vasculitis or autoimmune encephalitis. We here compared patients with mild Post-COVID-19 syndrome and persistent headache (persistent Post-COVID-19 headache) lasting longer than 12 weeks after the initial serological diagnosis, to patients with mild and severe COVID-19 and COVID-19-negative controls. Levels of neurofilament light chain and glial fibrillary astrocytic protein, i.e. markers of neuronal damage and reactive astrogliosis, were lower in blood from patients with persistent Post-COVID-19 headache compared to patients with severe COVID-19. Hence, our pilot serological study indicates that long-term Post-COVID-19 headache may not be a sign of underlying neuronal damage or neuroinflammation. Post-acute sequelae of SARS-CoV-2 infection Post-COVID-19 Headache NfL GFAP Biomarkers Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system Alexandru Odainic verfasserin aut Natalie Gancarczyk verfasserin aut Luisa Kaluza verfasserin aut Christian P. Strassburg verfasserin aut Xenia A. K. Kersting verfasserin aut Joseph M. Johnson verfasserin aut Ullrich Wüllner verfasserin aut Susanne V. Schmidt verfasserin aut Jacob Nattermann verfasserin aut Gabor C. Petzold verfasserin aut In Neurological Research and Practice BMC, 2019 4(2022), 1, Seite 7 (DE-627)1038162947 25243489 nnns volume:4 year:2022 number:1 pages:7 https://doi.org/10.1186/s42466-022-00217-5 kostenfrei https://doaj.org/article/327e6e4c09b34600864468cf80edde8e kostenfrei https://doi.org/10.1186/s42466-022-00217-5 kostenfrei https://doaj.org/toc/2524-3489 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2022 1 7 |
spelling |
10.1186/s42466-022-00217-5 doi (DE-627)DOAJ027378985 (DE-599)DOAJ327e6e4c09b34600864468cf80edde8e DE-627 ger DE-627 rakwb eng RC321-571 RC346-429 Laura de Boni verfasserin aut No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading symptom of Post-COVID diseases associated with neuronal damage such as vasculitis or autoimmune encephalitis. We here compared patients with mild Post-COVID-19 syndrome and persistent headache (persistent Post-COVID-19 headache) lasting longer than 12 weeks after the initial serological diagnosis, to patients with mild and severe COVID-19 and COVID-19-negative controls. Levels of neurofilament light chain and glial fibrillary astrocytic protein, i.e. markers of neuronal damage and reactive astrogliosis, were lower in blood from patients with persistent Post-COVID-19 headache compared to patients with severe COVID-19. Hence, our pilot serological study indicates that long-term Post-COVID-19 headache may not be a sign of underlying neuronal damage or neuroinflammation. Post-acute sequelae of SARS-CoV-2 infection Post-COVID-19 Headache NfL GFAP Biomarkers Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system Alexandru Odainic verfasserin aut Natalie Gancarczyk verfasserin aut Luisa Kaluza verfasserin aut Christian P. Strassburg verfasserin aut Xenia A. K. Kersting verfasserin aut Joseph M. Johnson verfasserin aut Ullrich Wüllner verfasserin aut Susanne V. Schmidt verfasserin aut Jacob Nattermann verfasserin aut Gabor C. Petzold verfasserin aut In Neurological Research and Practice BMC, 2019 4(2022), 1, Seite 7 (DE-627)1038162947 25243489 nnns volume:4 year:2022 number:1 pages:7 https://doi.org/10.1186/s42466-022-00217-5 kostenfrei https://doaj.org/article/327e6e4c09b34600864468cf80edde8e kostenfrei https://doi.org/10.1186/s42466-022-00217-5 kostenfrei https://doaj.org/toc/2524-3489 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2022 1 7 |
allfields_unstemmed |
10.1186/s42466-022-00217-5 doi (DE-627)DOAJ027378985 (DE-599)DOAJ327e6e4c09b34600864468cf80edde8e DE-627 ger DE-627 rakwb eng RC321-571 RC346-429 Laura de Boni verfasserin aut No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading symptom of Post-COVID diseases associated with neuronal damage such as vasculitis or autoimmune encephalitis. We here compared patients with mild Post-COVID-19 syndrome and persistent headache (persistent Post-COVID-19 headache) lasting longer than 12 weeks after the initial serological diagnosis, to patients with mild and severe COVID-19 and COVID-19-negative controls. Levels of neurofilament light chain and glial fibrillary astrocytic protein, i.e. markers of neuronal damage and reactive astrogliosis, were lower in blood from patients with persistent Post-COVID-19 headache compared to patients with severe COVID-19. Hence, our pilot serological study indicates that long-term Post-COVID-19 headache may not be a sign of underlying neuronal damage or neuroinflammation. Post-acute sequelae of SARS-CoV-2 infection Post-COVID-19 Headache NfL GFAP Biomarkers Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system Alexandru Odainic verfasserin aut Natalie Gancarczyk verfasserin aut Luisa Kaluza verfasserin aut Christian P. Strassburg verfasserin aut Xenia A. K. Kersting verfasserin aut Joseph M. Johnson verfasserin aut Ullrich Wüllner verfasserin aut Susanne V. Schmidt verfasserin aut Jacob Nattermann verfasserin aut Gabor C. Petzold verfasserin aut In Neurological Research and Practice BMC, 2019 4(2022), 1, Seite 7 (DE-627)1038162947 25243489 nnns volume:4 year:2022 number:1 pages:7 https://doi.org/10.1186/s42466-022-00217-5 kostenfrei https://doaj.org/article/327e6e4c09b34600864468cf80edde8e kostenfrei https://doi.org/10.1186/s42466-022-00217-5 kostenfrei https://doaj.org/toc/2524-3489 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2022 1 7 |
allfieldsGer |
10.1186/s42466-022-00217-5 doi (DE-627)DOAJ027378985 (DE-599)DOAJ327e6e4c09b34600864468cf80edde8e DE-627 ger DE-627 rakwb eng RC321-571 RC346-429 Laura de Boni verfasserin aut No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading symptom of Post-COVID diseases associated with neuronal damage such as vasculitis or autoimmune encephalitis. We here compared patients with mild Post-COVID-19 syndrome and persistent headache (persistent Post-COVID-19 headache) lasting longer than 12 weeks after the initial serological diagnosis, to patients with mild and severe COVID-19 and COVID-19-negative controls. Levels of neurofilament light chain and glial fibrillary astrocytic protein, i.e. markers of neuronal damage and reactive astrogliosis, were lower in blood from patients with persistent Post-COVID-19 headache compared to patients with severe COVID-19. Hence, our pilot serological study indicates that long-term Post-COVID-19 headache may not be a sign of underlying neuronal damage or neuroinflammation. Post-acute sequelae of SARS-CoV-2 infection Post-COVID-19 Headache NfL GFAP Biomarkers Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system Alexandru Odainic verfasserin aut Natalie Gancarczyk verfasserin aut Luisa Kaluza verfasserin aut Christian P. Strassburg verfasserin aut Xenia A. K. Kersting verfasserin aut Joseph M. Johnson verfasserin aut Ullrich Wüllner verfasserin aut Susanne V. Schmidt verfasserin aut Jacob Nattermann verfasserin aut Gabor C. Petzold verfasserin aut In Neurological Research and Practice BMC, 2019 4(2022), 1, Seite 7 (DE-627)1038162947 25243489 nnns volume:4 year:2022 number:1 pages:7 https://doi.org/10.1186/s42466-022-00217-5 kostenfrei https://doaj.org/article/327e6e4c09b34600864468cf80edde8e kostenfrei https://doi.org/10.1186/s42466-022-00217-5 kostenfrei https://doaj.org/toc/2524-3489 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2022 1 7 |
allfieldsSound |
10.1186/s42466-022-00217-5 doi (DE-627)DOAJ027378985 (DE-599)DOAJ327e6e4c09b34600864468cf80edde8e DE-627 ger DE-627 rakwb eng RC321-571 RC346-429 Laura de Boni verfasserin aut No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading symptom of Post-COVID diseases associated with neuronal damage such as vasculitis or autoimmune encephalitis. We here compared patients with mild Post-COVID-19 syndrome and persistent headache (persistent Post-COVID-19 headache) lasting longer than 12 weeks after the initial serological diagnosis, to patients with mild and severe COVID-19 and COVID-19-negative controls. Levels of neurofilament light chain and glial fibrillary astrocytic protein, i.e. markers of neuronal damage and reactive astrogliosis, were lower in blood from patients with persistent Post-COVID-19 headache compared to patients with severe COVID-19. Hence, our pilot serological study indicates that long-term Post-COVID-19 headache may not be a sign of underlying neuronal damage or neuroinflammation. Post-acute sequelae of SARS-CoV-2 infection Post-COVID-19 Headache NfL GFAP Biomarkers Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system Alexandru Odainic verfasserin aut Natalie Gancarczyk verfasserin aut Luisa Kaluza verfasserin aut Christian P. Strassburg verfasserin aut Xenia A. K. Kersting verfasserin aut Joseph M. Johnson verfasserin aut Ullrich Wüllner verfasserin aut Susanne V. Schmidt verfasserin aut Jacob Nattermann verfasserin aut Gabor C. Petzold verfasserin aut In Neurological Research and Practice BMC, 2019 4(2022), 1, Seite 7 (DE-627)1038162947 25243489 nnns volume:4 year:2022 number:1 pages:7 https://doi.org/10.1186/s42466-022-00217-5 kostenfrei https://doaj.org/article/327e6e4c09b34600864468cf80edde8e kostenfrei https://doi.org/10.1186/s42466-022-00217-5 kostenfrei https://doaj.org/toc/2524-3489 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2022 1 7 |
language |
English |
source |
In Neurological Research and Practice 4(2022), 1, Seite 7 volume:4 year:2022 number:1 pages:7 |
sourceStr |
In Neurological Research and Practice 4(2022), 1, Seite 7 volume:4 year:2022 number:1 pages:7 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Post-acute sequelae of SARS-CoV-2 infection Post-COVID-19 Headache NfL GFAP Biomarkers Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system |
isfreeaccess_bool |
true |
container_title |
Neurological Research and Practice |
authorswithroles_txt_mv |
Laura de Boni @@aut@@ Alexandru Odainic @@aut@@ Natalie Gancarczyk @@aut@@ Luisa Kaluza @@aut@@ Christian P. Strassburg @@aut@@ Xenia A. K. Kersting @@aut@@ Joseph M. Johnson @@aut@@ Ullrich Wüllner @@aut@@ Susanne V. Schmidt @@aut@@ Jacob Nattermann @@aut@@ Gabor C. Petzold @@aut@@ |
publishDateDaySort_date |
2022-01-01T00:00:00Z |
hierarchy_top_id |
1038162947 |
id |
DOAJ027378985 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ027378985</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502100627.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/s42466-022-00217-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ027378985</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ327e6e4c09b34600864468cf80edde8e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC321-571</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC346-429</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Laura de Boni</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading symptom of Post-COVID diseases associated with neuronal damage such as vasculitis or autoimmune encephalitis. We here compared patients with mild Post-COVID-19 syndrome and persistent headache (persistent Post-COVID-19 headache) lasting longer than 12 weeks after the initial serological diagnosis, to patients with mild and severe COVID-19 and COVID-19-negative controls. Levels of neurofilament light chain and glial fibrillary astrocytic protein, i.e. markers of neuronal damage and reactive astrogliosis, were lower in blood from patients with persistent Post-COVID-19 headache compared to patients with severe COVID-19. Hence, our pilot serological study indicates that long-term Post-COVID-19 headache may not be a sign of underlying neuronal damage or neuroinflammation.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Post-acute sequelae of SARS-CoV-2 infection</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Post-COVID-19</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Headache</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">NfL</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">GFAP</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neurosciences. Biological psychiatry. Neuropsychiatry</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neurology. Diseases of the nervous system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alexandru Odainic</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Natalie Gancarczyk</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Luisa Kaluza</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Christian P. Strassburg</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Xenia A. K. Kersting</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Joseph M. Johnson</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ullrich Wüllner</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Susanne V. Schmidt</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jacob Nattermann</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Gabor C. Petzold</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Neurological Research and Practice</subfield><subfield code="d">BMC, 2019</subfield><subfield code="g">4(2022), 1, Seite 7</subfield><subfield code="w">(DE-627)1038162947</subfield><subfield code="x">25243489</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1186/s42466-022-00217-5</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/327e6e4c09b34600864468cf80edde8e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1186/s42466-022-00217-5</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2524-3489</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">2022</subfield><subfield code="e">1</subfield><subfield code="h">7</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Laura de Boni |
spellingShingle |
Laura de Boni misc RC321-571 misc RC346-429 misc Post-acute sequelae of SARS-CoV-2 infection misc Post-COVID-19 misc Headache misc NfL misc GFAP misc Biomarkers misc Neurosciences. Biological psychiatry. Neuropsychiatry misc Neurology. Diseases of the nervous system No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache |
authorStr |
Laura de Boni |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1038162947 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RC321-571 |
illustrated |
Not Illustrated |
issn |
25243489 |
topic_title |
RC321-571 RC346-429 No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache Post-acute sequelae of SARS-CoV-2 infection Post-COVID-19 Headache NfL GFAP Biomarkers |
topic |
misc RC321-571 misc RC346-429 misc Post-acute sequelae of SARS-CoV-2 infection misc Post-COVID-19 misc Headache misc NfL misc GFAP misc Biomarkers misc Neurosciences. Biological psychiatry. Neuropsychiatry misc Neurology. Diseases of the nervous system |
topic_unstemmed |
misc RC321-571 misc RC346-429 misc Post-acute sequelae of SARS-CoV-2 infection misc Post-COVID-19 misc Headache misc NfL misc GFAP misc Biomarkers misc Neurosciences. Biological psychiatry. Neuropsychiatry misc Neurology. Diseases of the nervous system |
topic_browse |
misc RC321-571 misc RC346-429 misc Post-acute sequelae of SARS-CoV-2 infection misc Post-COVID-19 misc Headache misc NfL misc GFAP misc Biomarkers misc Neurosciences. Biological psychiatry. Neuropsychiatry misc Neurology. Diseases of the nervous system |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Neurological Research and Practice |
hierarchy_parent_id |
1038162947 |
hierarchy_top_title |
Neurological Research and Practice |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1038162947 |
title |
No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache |
ctrlnum |
(DE-627)DOAJ027378985 (DE-599)DOAJ327e6e4c09b34600864468cf80edde8e |
title_full |
No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache |
author_sort |
Laura de Boni |
journal |
Neurological Research and Practice |
journalStr |
Neurological Research and Practice |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2022 |
contenttype_str_mv |
txt |
container_start_page |
7 |
author_browse |
Laura de Boni Alexandru Odainic Natalie Gancarczyk Luisa Kaluza Christian P. Strassburg Xenia A. K. Kersting Joseph M. Johnson Ullrich Wüllner Susanne V. Schmidt Jacob Nattermann Gabor C. Petzold |
container_volume |
4 |
class |
RC321-571 RC346-429 |
format_se |
Elektronische Aufsätze |
author-letter |
Laura de Boni |
doi_str_mv |
10.1186/s42466-022-00217-5 |
author2-role |
verfasserin |
title_sort |
no serological evidence for neuronal damage or reactive gliosis in neuro-covid-19 patients with long-term persistent headache |
callnumber |
RC321-571 |
title_auth |
No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache |
abstract |
Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading symptom of Post-COVID diseases associated with neuronal damage such as vasculitis or autoimmune encephalitis. We here compared patients with mild Post-COVID-19 syndrome and persistent headache (persistent Post-COVID-19 headache) lasting longer than 12 weeks after the initial serological diagnosis, to patients with mild and severe COVID-19 and COVID-19-negative controls. Levels of neurofilament light chain and glial fibrillary astrocytic protein, i.e. markers of neuronal damage and reactive astrogliosis, were lower in blood from patients with persistent Post-COVID-19 headache compared to patients with severe COVID-19. Hence, our pilot serological study indicates that long-term Post-COVID-19 headache may not be a sign of underlying neuronal damage or neuroinflammation. |
abstractGer |
Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading symptom of Post-COVID diseases associated with neuronal damage such as vasculitis or autoimmune encephalitis. We here compared patients with mild Post-COVID-19 syndrome and persistent headache (persistent Post-COVID-19 headache) lasting longer than 12 weeks after the initial serological diagnosis, to patients with mild and severe COVID-19 and COVID-19-negative controls. Levels of neurofilament light chain and glial fibrillary astrocytic protein, i.e. markers of neuronal damage and reactive astrogliosis, were lower in blood from patients with persistent Post-COVID-19 headache compared to patients with severe COVID-19. Hence, our pilot serological study indicates that long-term Post-COVID-19 headache may not be a sign of underlying neuronal damage or neuroinflammation. |
abstract_unstemmed |
Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading symptom of Post-COVID diseases associated with neuronal damage such as vasculitis or autoimmune encephalitis. We here compared patients with mild Post-COVID-19 syndrome and persistent headache (persistent Post-COVID-19 headache) lasting longer than 12 weeks after the initial serological diagnosis, to patients with mild and severe COVID-19 and COVID-19-negative controls. Levels of neurofilament light chain and glial fibrillary astrocytic protein, i.e. markers of neuronal damage and reactive astrogliosis, were lower in blood from patients with persistent Post-COVID-19 headache compared to patients with severe COVID-19. Hence, our pilot serological study indicates that long-term Post-COVID-19 headache may not be a sign of underlying neuronal damage or neuroinflammation. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
1 |
title_short |
No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache |
url |
https://doi.org/10.1186/s42466-022-00217-5 https://doaj.org/article/327e6e4c09b34600864468cf80edde8e https://doaj.org/toc/2524-3489 |
remote_bool |
true |
author2 |
Alexandru Odainic Natalie Gancarczyk Luisa Kaluza Christian P. Strassburg Xenia A. K. Kersting Joseph M. Johnson Ullrich Wüllner Susanne V. Schmidt Jacob Nattermann Gabor C. Petzold |
author2Str |
Alexandru Odainic Natalie Gancarczyk Luisa Kaluza Christian P. Strassburg Xenia A. K. Kersting Joseph M. Johnson Ullrich Wüllner Susanne V. Schmidt Jacob Nattermann Gabor C. Petzold |
ppnlink |
1038162947 |
callnumber-subject |
RC - Internal Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1186/s42466-022-00217-5 |
callnumber-a |
RC321-571 |
up_date |
2024-07-04T01:28:05.810Z |
_version_ |
1803609949669949440 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ027378985</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502100627.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/s42466-022-00217-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ027378985</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ327e6e4c09b34600864468cf80edde8e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC321-571</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC346-429</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Laura de Boni</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a leading symptom of Post-COVID diseases associated with neuronal damage such as vasculitis or autoimmune encephalitis. We here compared patients with mild Post-COVID-19 syndrome and persistent headache (persistent Post-COVID-19 headache) lasting longer than 12 weeks after the initial serological diagnosis, to patients with mild and severe COVID-19 and COVID-19-negative controls. Levels of neurofilament light chain and glial fibrillary astrocytic protein, i.e. markers of neuronal damage and reactive astrogliosis, were lower in blood from patients with persistent Post-COVID-19 headache compared to patients with severe COVID-19. Hence, our pilot serological study indicates that long-term Post-COVID-19 headache may not be a sign of underlying neuronal damage or neuroinflammation.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Post-acute sequelae of SARS-CoV-2 infection</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Post-COVID-19</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Headache</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">NfL</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">GFAP</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neurosciences. Biological psychiatry. Neuropsychiatry</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neurology. Diseases of the nervous system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alexandru Odainic</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Natalie Gancarczyk</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Luisa Kaluza</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Christian P. Strassburg</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Xenia A. K. Kersting</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Joseph M. Johnson</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ullrich Wüllner</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Susanne V. Schmidt</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jacob Nattermann</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Gabor C. Petzold</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Neurological Research and Practice</subfield><subfield code="d">BMC, 2019</subfield><subfield code="g">4(2022), 1, Seite 7</subfield><subfield code="w">(DE-627)1038162947</subfield><subfield code="x">25243489</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1186/s42466-022-00217-5</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/327e6e4c09b34600864468cf80edde8e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1186/s42466-022-00217-5</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2524-3489</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">2022</subfield><subfield code="e">1</subfield><subfield code="h">7</subfield></datafield></record></collection>
|
score |
7.400589 |